Health Canada drug identification number

DIN 02284863 — MYOZYME 50 MG

MYOZYME is a powder for solution of Alglucosidase alfa marketed by SANOFI-AVENTIS CANADA INC. The full Alglucosidase alfa monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.

DIN
02284863
Brand name
MYOZYME
Active ingredient
Alglucosidase alfa
Strength
50 MG
Dosage form
POWDER FOR SOLUTION
Route
INTRAVENOUS
Manufacturer
SANOFI-AVENTIS CANADA INC
Health Canada status
MARKETED
Drug class
Enzyme replacement therapy (acid alpha-glucosidase)

Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.

Rejoining the server...

Rejoin failed... trying again in seconds.

Failed to rejoin.
Please retry or reload the page.

The session has been paused by the server.

Failed to resume the session.
Please retry or reload the page.